IP Library Granted Patent US 11,078,256
Granted Patent B2
US 11,078,256 · App. 16/452,178 · Granted Aug 3, 2021

Methods and compositions for inhibiting cancer cell growth

Inventor: Charles F. Streckfus (Houston, TX)
Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
C07K14/8146A61K9/0019A61K9/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,078,256
App. No.
16/452,178
Granted
Aug 3, 2021
Kind
B2
Abstract

Described are methods and compositions that provide for generating synthetic or recombinant proline rich peptides. In some aspects, p1978 compositions are used to inhibit breast cancer cell growth and thus provided is a method for treating and preventing breast cancer cell growth in a mammal.

Claims (10)

1. A method of treating or preventing a cancer in a subject comprising administering an effective amount of a composition comprising a recombinant polypeptide comprising the amino acid sequence of p1978 (SEQ ID NO: 1).

2. The method of claim 1 , wherein the cancer is a breast cancer.

3. The method of claim 2 , wherein the breast cancer is triple negative breast cancer.

4. The method of claim 1 , wherein the composition is administered by intravenous injection or catheter delivery.

5. The method of claim 2 , wherein the composition is administered by intravenous injection or catheter delivery.

6. The method of claim 3 , wherein the composition is administered by intravenous injection or catheter delivery.

7. The method of claim 1 , wherein the recombinant polypeptide is a fusion protein comprising the amino acid sequence of p1978 (SEQ ID NO: 1) and a heterologous polypeptide sequence.

8. The method of claim 1 , wherein the recombinant polypeptide is no more than 50 amino acids in length.

9. The method of claim 1 , wherein the recombinant polypeptide is no more than 20 amino acids in length.

10. The method of claim 1 , wherein the N-terminus, the C-terminus or both are blocked.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: STRECKFUS, CHARLES
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 052081/0609 →
Continuity (2)
Provisional Application 62690034 · Jun 26, 2018
Related Publication 20190389938A1 · Dec 26, 2019